Bill > A2332

This bill requires health insurance coverage for testing for the breast cancer 1 (BRCA1) and breast cancer 2 (BRCA2) genes. Specifically, the bill mandates that health insurance policies and contracts delivered, issued, executed, or renewed in the State of New Jersey must cover expenses incurred for BRCA1 and BRCA2 gene testing. Additionally, the bill establishes that a positive test result for BRCA1 or BRCA2 genes can be considered "positive genetic testing" for breast cancer, allowing for additional testing as authorized under current law. The bill applies to various types of health insurance plans, including hospital service corporation contracts, medical service corporation contracts, health service corporation contracts, individual and group health insurance policies, and health maintenance organization enrollee agreements. The provisions of the bill take effect 90 days after enactment and apply to policies and contracts delivered, issued, executed, or renewed on or after that date.

Business and Industry

https://www.njleg.state.nj.us/bill-search/2024/A2332